Unexplained Tiredness in Clinical Practice

 

Unexplained Tiredness in Clinical Practice: A Comprehensive Approach to Diagnostic Evaluation and Management

Dr Neeraj Manikath , claude.ai

Abstract

Fatigue remains one of the most common yet challenging presenting complaints in internal medicine, affecting 10-25% of patients in primary care settings. When initial evaluation fails to reveal an obvious cause, clinicians face a diagnostic dilemma that requires systematic investigation while avoiding unnecessary testing. This review provides a structured approach to evaluating unexplained tiredness, highlighting diagnostic pearls, evidence-based strategies, and practical management considerations for the practicing internist.

Introduction

Fatigue—defined as an overwhelming sense of tiredness, lack of energy, or feeling of exhaustion—represents a final common pathway for numerous physiological and psychological processes. While acute fatigue typically resolves with rest, persistent fatigue lasting more than one month warrants systematic evaluation. The challenge lies not in recognizing common causes, but in identifying subtle presentations of serious conditions while avoiding the pitfalls of over-investigation.

The prevalence of chronic fatigue in community studies ranges from 10% to 40%, with only 0.5-2.5% meeting criteria for Chronic Fatigue Syndrome (CFS/ME). Women report fatigue 1.5 to 2 times more frequently than men, and prevalence peaks in middle age. Understanding the breadth of differential diagnoses and developing a rational investigative approach is essential for effective patient management.

Initial Clinical Assessment: The Foundation of Diagnosis

History-Taking: Beyond the Obvious

The clinical history remains paramount. Duration, pattern, associated symptoms, and impact on daily functioning provide crucial diagnostic clues. Key questions should explore:

Temporal characteristics: Sudden onset suggests infection or acute medical illness, while gradual progression over months points toward chronic disease processes, endocrine disorders, or psychological causes. Morning fatigue improving throughout the day suggests depression, whereas fatigue worsening with activity characterizes post-exertional malaise in ME/CFS.

Associated symptoms: Documenting accompanying features often illuminates the diagnosis. Weight changes, temperature intolerance, skin alterations, and menstrual irregularities suggest endocrine pathology. Arthralgia, rashes, and fever point toward inflammatory or autoimmune conditions. Dyspnea and orthopnea indicate cardiopulmonary disease.

Pearl #1: Ask about snoring and witnessed apneas. Obstructive sleep apnea (OSA) affects 10-30% of adults and commonly presents solely as daytime fatigue without classic hypersomnolence. The Epworth Sleepiness Scale lacks sensitivity for OSA presenting with fatigue alone.

Medication review: Polypharmacy contributes significantly to fatigue, particularly in older adults. Beta-blockers, antihistamines, benzodiazepines, opioids, antihypertensives, and many psychotropic medications cause dose-dependent sedation. Statins may cause fatigue independent of myopathy.

Occupational and lifestyle factors: Shift work, inadequate sleep hygiene, excessive caffeine, alcohol use, and physical inactivity all contribute to chronic fatigue. Screen systematically for these modifiable factors before extensive investigation.

Physical Examination: Targeted and Thorough

While often unrevealing, careful examination can identify findings missed in cursory assessment. Pallor suggests anemia, thyroid enlargement or eye signs point to thyroid disease, and lymphadenopathy raises concern for malignancy or chronic infection. Hepatosplenomegaly, cardiac murmurs, and signs of heart failure require immediate attention.

Pearl #2: Examine the tongue. A smooth, beefy-red tongue suggests B12 deficiency or iron deficiency anemia, while a pale tongue reinforces anemia suspicion. Geographic tongue may indicate nutritional deficiencies.

Check orthostatic vital signs. A sustained heart rate increase of ≥30 bpm (≥40 bpm in adolescents) without corresponding blood pressure drop suggests Postural Orthostatic Tachycardia Syndrome (POTS), increasingly recognized as causing debilitating fatigue.

Laboratory Investigation: The Evidence-Based Approach

First-Line Investigations

Initial screening should be guided by clinical probability rather than reflexive panel ordering. Evidence-based first-line tests include:

Complete blood count: Identifies anemia (affecting 10% of women and 5% of men), which frequently presents as isolated fatigue. Mean corpuscular volume guides further investigation—microcytic suggests iron deficiency or thalassemia, macrocytic points toward B12, folate deficiency, or alcohol excess.

Thyroid function tests: Subclinical hypothyroidism (elevated TSH with normal free T4) affects 4-10% of adults and may cause fatigue. Treatment remains controversial with TSH <10 mIU/L, though symptoms often improve with levothyroxine replacement.

Metabolic panel: Detects electrolyte abnormalities, renal dysfunction, and hyperglycemia. Hypercalcemia, even mild elevations, causes significant fatigue and may indicate primary hyperparathyroidism or malignancy.

Liver function tests: Elevated transaminases may reveal chronic hepatitis, non-alcoholic fatty liver disease, or medication toxicity. Isolated alkaline phosphatase elevation warrants bone evaluation or cholestatic liver disease consideration.

Pearl #3: Don't forget ferritin. Serum ferritin <30-50 μg/L without anemia causes fatigue and responds to iron supplementation. Traditional cutoffs of <15 μg/L miss many cases. However, ferritin is an acute-phase reactant—normal or elevated levels don't exclude functional iron deficiency. Check transferrin saturation when suspicion remains high.

Inflammatory markers: ESR and CRP, while non-specific, help screen for occult inflammatory conditions. Markedly elevated values (ESR >100 mm/hr) suggest infection, malignancy, or vasculitis. Normal values substantially reduce probability of serious inflammatory disease.

Glucose testing: Fasting glucose or HbA1c identifies diabetes, but also check for glucose dysregulation. Reactive hypoglycemia and pre-diabetes contribute to energy fluctuations and chronic fatigue.

Second-Line Investigations: When to Dig Deeper

If initial screening proves unrevealing and fatigue persists, consider additional testing based on clinical context:

Vitamin D levels: Deficiency (<20 ng/mL) is epidemic, affecting up to 40% of adults in some populations, and associates with fatigue, muscle weakness, and mood disturbances. Supplementation to levels >30 ng/mL may improve symptoms, though evidence remains mixed.

Vitamin B12 and folate: Test in those with risk factors including vegetarians, elderly patients, those with gastrointestinal disease, or on metformin or proton pump inhibitors. Normal B12 doesn't exclude deficiency—methylmalonic acid and homocysteine provide greater sensitivity for tissue deficiency.

Celiac serology: Tissue transglutaminase antibodies (IgA) with total IgA to avoid false negatives. Celiac disease affects 1% of the population, often presenting with isolated fatigue without gastrointestinal symptoms.

Cortisol assessment: Early morning cortisol screens for Addison's disease if clinical suspicion exists (orthostatic hypotension, hyperpigmentation, hyponatremia). Random cortisol lacks utility. Late-night salivary cortisol or 24-hour urinary free cortisol evaluates for Cushing's syndrome when clinical features suggest it.

Pearl #4: Consider testing for sleep apnea even without classic symptoms. Home sleep studies have become accessible and cost-effective. Treat if apnea-hypopnea index >5 with symptoms or >15 regardless of symptoms.

The Hidden Culprits: Conditions Often Missed

Obstructive Sleep Apnea

OSA deserves emphasis as it's simultaneously common, under-recognized, and treatable. Beyond the stereotypical obese male snorer, OSA affects women (particularly post-menopausal), individuals of normal weight, and may present with fatigue, morning headaches, or concentration difficulties rather than sleepiness. Continuous positive airway pressure (CPAP) therapy demonstrates significant fatigue improvement in adherent patients.

Chronic Infections

Infectious mononucleosis: While acute EBV typically resolves, some patients develop prolonged fatigue lasting months. Heterophile antibodies (Monospot) may be negative early; confirm with EBV-specific serology.

Tuberculosis: Particularly in high-risk populations, TB may present insidiously with fatigue, night sweats, and weight loss. Maintain high suspicion in immigrants, immunocompromised patients, or those with relevant exposures.

HIV: Current guidelines recommend one-time screening for all adults. Early HIV infection often causes fatigue even before immunosuppression becomes evident.

Chronic hepatitis: Hepatitis B and C frequently present with fatigue as the predominant symptom. Screen high-risk populations including those born 1945-1965 (baby boomers) for hepatitis C.

Hack #1: For suspected chronic infection with negative initial tests, recheck inflammatory markers (ESR/CRP) and consider infectious disease consultation. Unusual organisms including Bartonella, Brucella, or endemic fungi may require specialized testing.

Endocrine Disorders Beyond Thyroid

Adrenal insufficiency: Often delayed in diagnosis due to non-specific presentation. Consider in patients with unexplained hypotension, hyponatremia, or those on chronic steroids. The diagnosis requires dynamic testing—random cortisol is insufficient.

Testosterone deficiency: In men with fatigue plus decreased libido, erectile dysfunction, or mood changes, check morning total testosterone. Levels <300 ng/dL warrant repeat testing and endocrine evaluation.

Growth hormone deficiency: Uncommon but consider in those with pituitary disease history or radiation exposure.

Cardiac Causes

Heart failure with preserved ejection fraction (HFpEF) comprises 50% of heart failure cases and commonly presents with fatigue rather than dyspnea. BNP or NT-proBNP elevation suggests cardiac etiology. Echocardiography demonstrates diastolic dysfunction. Even subtle valvular disease, particularly aortic stenosis in the elderly, may present with progressive fatigue.

Malignancy

While rare as a sole presentation, occult malignancy must be excluded in appropriate contexts. Age-appropriate cancer screening is essential. Concerning features include unintentional weight loss, fever, night sweats, or abnormal examination findings. Significantly elevated inflammatory markers warrant further investigation.

Autoimmune and Rheumatologic Conditions

Rheumatoid arthritis: May present with fatigue before joint symptoms become prominent. Check rheumatoid factor and anti-CCP antibodies if morning stiffness or joint symptoms emerge.

Systemic lupus erythematosus: Fatigue affects >80% of SLE patients. ANA screening is appropriate with multisystem symptoms, but positive ANA requires confirmatory testing given low specificity.

Polymyalgia rheumatica: Consider in patients over 50 with proximal muscle pain and stiffness. Markedly elevated ESR (often >50 mm/hr) supports diagnosis. Dramatic response to corticosteroids is characteristic.

Sjögren's syndrome: Often overlooked, presenting with dry eyes, dry mouth, and debilitating fatigue before more obvious features develop.

Pearl #5: Fatigue severity often doesn't correlate with disease activity markers in rheumatologic conditions. Treat the underlying disease but address fatigue as a specific symptom requiring multimodal management.

Medication-Related Fatigue

Beyond obvious sedating medications, consider:

• Statins (even without myopathy)
• Antihypertensives (especially beta-blockers, alpha-blockers, centrally-acting agents)
• Anticonvulsants
• Overused or inappropriately dosed thyroid replacement
• Proton pump inhibitors (via nutrient malabsorption)
• Antihistamines including "non-drowsy" formulations

Hack #2: When medication contribution is unclear, propose a therapeutic trial of discontinuation or dose reduction if medically safe. Improvement within 2-4 weeks suggests causation.

Psychological Causes: The Mind-Body Connection

Depression and anxiety account for a substantial proportion of unexplained fatigue cases. Depression may present primarily with somatic symptoms including fatigue, pain, and sleep disturbance rather than mood changes—so-called "masked depression." The PHQ-9 provides validated screening.

Chronic stress, including work-related burnout, significantly contributes to persistent fatigue. Inquire about life stressors, work environment, relationship issues, and caregiver burden.

Hack #3: Rather than dichotomizing organic versus psychological causes, recognize their frequent coexistence. Physical illness exacerbates mood disorders, and psychological distress amplifies somatic symptoms. Addressing both concurrently yields optimal outcomes.

Chronic Fatigue Syndrome/Myalgic Encephalomyelitis

When exhaustive investigation reveals no alternative explanation and specific criteria are met, consider CFS/ME diagnosis. Current diagnostic criteria require:

• Substantial reduction in activity level lasting >6 months
• Post-exertional malaise lasting >24 hours
• Unrefreshing sleep
• Plus either cognitive impairment or orthostatic intolerance

CFS/ME remains a diagnosis of exclusion requiring thorough evaluation first. No specific biomarkers exist. Management focuses on symptom control, pacing strategies to avoid post-exertional crashes, and treating comorbid conditions. Avoid dismissing patients or attributing symptoms solely to psychological causes.

Practical Management Strategies

When Investigation is Normal

Reassess the history: Review symptoms with fresh perspective. Patients may reveal previously unmentioned symptoms or patterns become clearer over time.

Optimize modifiable factors:

• Sleep hygiene counseling
• Regular moderate exercise (start low, progress slowly)
• Stress management and relaxation techniques
• Nutritional counseling
• Alcohol and caffeine moderation

Address comorbidities: Treat coexisting depression, anxiety, or pain syndromes that amplify fatigue perception.

Avoid over-investigation: Repetitive testing without new clinical information provides false reassurance and may identify incidental findings requiring unnecessary intervention. Set clear expectations about test limitations.

Therapeutic trials: Consider empiric treatment for conditions that are under-detected by standard testing:

• Iron supplementation for low-normal ferritin (with proper monitoring)
• Vitamin D supplementation to achieve levels >30 ng/mL
• Trial of CPAP if OSA suspected but testing unavailable

Pearl #6: Schedule follow-up rather than discharging patients with "normal" results. Longitudinal observation often reveals diagnosis over time as symptoms evolve or new features emerge.

Conclusion

Unexplained tiredness challenges the diagnostic acumen of even experienced clinicians. Success requires methodical evaluation, pattern recognition, and willingness to reconsider the diagnosis when initial investigation proves unrevealing. While exhaustive testing tempts, a targeted approach based on clinical probability and evidence-based investigation yields better outcomes with reduced cost and patient burden.

Remember that fatigue is subjective—its impact on the individual patient matters more than objective measures. Even when specific pathology remains elusive, symptom management, lifestyle optimization, and therapeutic relationship provide meaningful benefit. The art of medicine lies in balancing thorough investigation with avoidance of unnecessary testing, while maintaining the patient's confidence that their concerns are taken seriously.

Key Takeaways for Practice

1. Prioritize careful history and examination over reflexive test ordering
2. Screen systematically for sleep disorders, particularly OSA
3. Check ferritin and consider supplementation even without anemia
4. Don't overlook medication contributions to fatigue
5. Address psychological and physical contributors concurrently
6. Maintain longitudinal follow-up rather than discharging with normal initial tests
7. Set realistic expectations about diagnostic certainty and treatment timelines

References

1. Stadje R, et al. The differential diagnosis of tiredness: a systematic review. BMC Fam Pract. 2016;17:147.

2. Rosenthal TC, et al. Fatigue: an overview. Am Fam Physician. 2008;78(10):1173-1179.

3. Griffith JP, Zarrouf FA. A systematic review of chronic fatigue syndrome: don't assume it's depression. Prim Care Companion J Clin Psychiatry. 2008;10(2):120-128.

4. Chaudhuri A, Behan PO. Fatigue in neurological disorders. Lancet. 2004;363(9413):978-988.

5. Maisel AS, et al. Breathing not properly: new insights into the pathophysiology and diagnosis of heart failure. Rev Cardiovasc Med. 2002;3(2):63-70.

6. Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington, DC: National Academies Press; 2015.

7. Fukuda K, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med. 1994;121(12):953-959.

8. Verdon F, et al. Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. BMJ. 2003;326(7399):1124.

9. Goodnick PJ, et al. Treatment of chronic fatigue syndrome with venlafaxine. Am J Psychiatry. 1999;156(6):974-975.

10. Garland EM, et al. Postural tachycardia syndrome: beyond orthostatic intolerance. Curr Neurol Neurosci Rep. 2015;15(9):60.